X4 Pharmaceuticals, Inc.
NASDAQ:XFOR
0.7032 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.563 | 0 | 3.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 3.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.462 | 0.062 | 0.062 | 0.502 | 0.516 | 0.512 | 0.501 | 0.494 | 0.5 | 0.499 | 0.494 | 0.491 | 0.487 | 0.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Gross Profit
| 0.101 | -0.062 | 2.998 | -0.502 | -0.516 | -0.512 | -0.501 | -0.494 | -0.5 | -0.499 | -0.494 | -0.491 | -0.487 | -0.42 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 3.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.1 |
| Gross Profit Ratio
| 0.179 | 0 | 0.98 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 20.72 | 19.792 | 15.21 | 19.081 | 15.601 | 15.601 | 22.063 | 19.014 | 13.821 | 14.113 | 12.162 | 13.188 | 13.193 | 12.104 | 12.298 | 11.381 | 9.342 | 8.911 | 7.065 | 8.589 | 8.854 | 5.655 | 4.344 | 9.572 | 8.93 | 8.133 | 9.23 | 10.601 | 3.906 | 4.391 | 4.227 | 2.529 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 14.413 | 14.413 | 6.749 | 7.664 | 7.135 | 5.931 | 5.804 | 5.832 | 5.357 | 5.599 | 5.316 | 4.67 | 3.914 | 4.383 | 4.56 | 4.783 | 8.628 | 3.275 | 3.686 | 2.817 | 2.376 | 2.455 | 1.738 | 1.436 | 1.473 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | -7.172 | -7.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 13.278 | 17.435 | 9.927 | 8.133 | 10.204 | 10.204 | 7.241 | 6.563 | 6.749 | 7.664 | 7.135 | 5.931 | 5.804 | 5.832 | 5.357 | 5.599 | 5.316 | 4.67 | 3.914 | 4.383 | 4.56 | 4.783 | 8.628 | 3.275 | 3.686 | 2.817 | 2.376 | 2.455 | 1.738 | 1.436 | 1.473 | 1.24 |
| Other Expenses
| 0.144 | 0.105 | 0.212 | 0.017 | -29.892 | -29.892 | 5.288 | -3.513 | -0.059 | 0.06 | -1.149 | -0.074 | -0.635 | 0.186 | -0.745 | 0.228 | -0.486 | 0.041 | 0.038 | 0.052 | 0.149 | 0 | -0.006 | -0.006 | 0.001 | -0.074 | -0.073 | 0.086 | -0.028 | -0.001 | 0.016 | 0 |
| Operating Expenses
| 33.998 | 37.227 | 25.137 | 27.214 | 25.805 | 25.805 | 29.304 | 25.577 | 20.57 | 21.777 | 19.297 | 19.119 | 18.997 | 17.936 | 17.655 | 16.98 | 14.658 | 13.581 | 10.979 | 12.972 | 13.414 | 10.438 | 12.77 | 10.831 | 12.1 | 10.505 | 10.918 | 11.438 | 4.782 | 5.127 | 5.139 | 3.769 |
| Operating Income
| -33.897 | -37.289 | -25.199 | -27.214 | -25.805 | -25.805 | -22.907 | -25.577 | -20.57 | -21.268 | -29.055 | -19.119 | -18.997 | -17.936 | -17.655 | -16.98 | -14.658 | -10.581 | -10.875 | -16.976 | -13.414 | -10.438 | -9.472 | -12.847 | -12.616 | -10.95 | -11.606 | -13.056 | -5.644 | -5.827 | -5.7 | -3.869 |
| Operating Income Ratio
| -60.208 | 0 | -8.235 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5,885,000,000,000 | 0 | 0 | -3.527 | 0 | 0 | 0 | 0 | -2.706 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 124.748 | -14.458 | 6.102 | 25.181 | -29.892 | -29.892 | -1.109 | -3.513 | -0.638 | -0.674 | -10.907 | -0.136 | -0.635 | 0.155 | -0.745 | 0.228 | -0.486 | -0.121 | 0.142 | -4.518 | 0.149 | -0.105 | -0.006 | -0.006 | 0.001 | -0.074 | -0.12 | 0.091 | -0.479 | 0.761 | 0.61 | 0.369 |
| Income Before Tax
| 90.851 | -51.747 | -19.097 | -2.279 | -55.697 | -55.697 | -24.016 | -29.09 | -21.208 | -21.942 | -30.204 | -20.173 | -19.632 | -18.67 | -18.4 | -17.449 | -15.144 | -10.99 | -10.837 | -17.714 | -13.383 | -10.873 | -9.358 | -10.9 | -12.133 | -10.63 | -11.187 | -11.6 | -5.705 | -5.385 | -5.321 | -3.5 |
| Income Before Tax Ratio
| 161.369 | 0 | -6.241 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,133,333,333,333.333 | 0 | 0 | -3.663 | 0 | 0 | 0 | 0 | -2.674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.018 | 0.019 | 0.033 | 0.026 | 0.015 | 0.015 | 0.004 | 0.014 | 0.004 | 0.023 | 0.003 | 0.002 | 0.006 | 0.006 | 0 | 0.925 | -0.066 | 0.148 | -0.136 | 0.74 | 0.661 | 0.399 | 0.248 | 0.253 | 0.26 | 0.193 | 0.243 | 0.429 | 0.416 | 1.018 | 0.808 | 0 |
| Net Income
| 90.833 | -51.766 | -19.13 | -2.305 | -55.712 | -55.712 | -24.02 | -29.104 | -21.212 | -21.965 | -30.207 | -20.175 | -19.638 | -18.676 | -18.4 | -17.449 | -15.144 | -11.138 | -10.837 | -17.714 | -13.383 | -10.873 | -9.358 | -10.9 | -12.133 | -10.63 | -11.187 | -11.6 | -5.705 | -5.385 | -5.321 | -3.5 |
| Net Income Ratio
| 161.337 | 0 | -6.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,133,333,333,333.333 | 0 | 0 | -3.713 | 0 | 0 | 0 | 0 | -2.674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.45 | -0.26 | -0.096 | -0.012 | -0.33 | -0.38 | -0.24 | -0.29 | -0.6 | -0.65 | -1.04 | -0.76 | -0.74 | -0.9 | -0.91 | -0.87 | -0.76 | -0.56 | -0.66 | -1.22 | -1.02 | -6.33 | -5.45 | -4.57 | -5.09 | -4.46 | -10.09 | -6.43 | -6.15 | -5.8 | -5.73 | -8.81 |
| EPS Diluted
| 0.45 | -0.26 | -0.096 | -0.012 | -0.33 | -0.38 | -0.24 | -0.29 | -0.6 | -0.65 | -1.04 | -0.76 | -0.74 | -0.9 | -0.91 | -0.87 | -0.76 | -0.56 | -0.66 | -1.22 | -1.02 | -6.33 | -5.45 | -4.57 | -5.09 | -4.46 | -10.09 | -6.43 | -6.15 | -5.8 | -5.73 | -8.81 |
| EBITDA
| -33.703 | -37.227 | -25.137 | -25.705 | -25.805 | -25.805 | -29.304 | -25.577 | -20.493 | -21.581 | -9.539 | -19.059 | -18.997 | -17.642 | -17.655 | -16.606 | -14.658 | -10.208 | -11.083 | -12.429 | -12.847 | -10.349 | -9.07 | -10.605 | -11.835 | -10.317 | -10.777 | -11.21 | -4.762 | -5.08 | -5.073 | -3.769 |
| EBITDA Ratio
| -59.863 | 0 | -8.215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5,885,000,000,000 | 0 | 0 | -3.403 | 0 | 0 | 0 | 0 | -2.591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |